Adiponectin is down-regulated in bone marrow interstitial fluid in hematological malignancy.

Area of Science:

• Biochemistry
• Oncology
• Hematology

Background:

• Adipokines are implicated in various cancers, with established links to serum levels and malignancies.
• The role and expression of adipokines within bone marrow fluid concerning hematological malignancies remain largely uninvestigated.

Purpose of the Study:

• To quantify adipokine concentrations (adiponectin, leptin, resistin) in bone marrow interstitial fluid.
• To explore correlations between bone marrow adipokines, body mass index, and hematological malignancy.
• To investigate adipokine expression specifically in leukemia patients.

Main Methods:

• Analysis of 80 bone marrow samples from patients with hematological malignancy and control groups.
• Measurement of adiponectin, leptin, and resistin levels in bone marrow interstitial fluid.
• Statistical assessment of correlations between adipokines, BMI, and clinical parameters.

Main Results:

• Patients with hematological malignancy exhibited significantly lower levels of adiponectin.
• Adiponectin levels were notably decreased in bone marrow samples from leukemia patients.
• A significant inverse correlation was observed between adiponectin levels and body mass index.

Conclusions:

• Adiponectin is decreased in the bone marrow of patients diagnosed with leukemia.
• Bone marrow adiponectin levels show a negative correlation with body mass index in the studied population.